lumykras
amgen europe bv - sotorasib - Καρκίνωμα, μη μικροκυτταρικός πνεύμονας - Αντινεοπλασματικοί παράγοντες - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
berlex gr.tab 10mg/tab
gap a.e. ΑΓΗΣΙΛΑΟΥ 46, 17341 ΑΓ. ΔΗΜΗΤΡΙΟΣ 210.9310980 - rabeprazole sodium monohydrate - gr.tab (ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΔΙΣΚΙΟ) - 10mg/tab - rabeprazole sodium monohydrate 10,47mg - rabeprazole
berlex gr.tab 20mg/tab
gap a.e. ΑΓΗΣΙΛΑΟΥ 46, 17341 ΑΓ. ΔΗΜΗΤΡΙΟΣ 210.9310980 - rabeprazole sodium monohydrate - gr.tab (ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΔΙΣΚΙΟ) - 20mg/tab - rabeprazole sodium monohydrate 20,94mg - rabeprazole
omeprazol vian
vian sa - omeprazole sodium - powder & solvent for solution for injection, solution for injection - 40mg/vial, - 8000028071 - omeprazole sodium - 42.6 mg - omeprazole
omeprazole/teva 40mg/vial pd.sol.inf
teva pharma b.v., utrecht, the netherlands - omeprazole - ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 40mg/vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
losec mups 10mg/tab γαστροανθεκτικο δισκιο
cheplapharm arzneimittel gmbh, greifswald, germany (0000012441) ziegelhof 24, greifswald, 17489 - omeprazole magnesium - ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΔΙΣΚΙΟ - 10mg/tab - ineof01387 omeprazole magnesium 10.300000 mg - omeprazole
losec mups 20mg/tab γαστροανθεκτικο δισκιο
cheplapharm arzneimittel gmbh, greifswald, germany (0000012441) ziegelhof 24, greifswald, 17489 - omeprazole magnesium - ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΔΙΣΚΙΟ - 20mg/tab - ineof01387 omeprazole magnesium 20.600000 mg - omeprazole
losec mups 40mg/tab γαστροανθεκτικο δισκιο
cheplapharm arzneimittel gmbh, greifswald, germany (0000012441) ziegelhof 24, greifswald, 17489 - omeprazole magnesium - ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΔΙΣΚΙΟ - 40mg/tab - ineof01387 omeprazole magnesium 41.300000 mg - omeprazole
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - Καρκίνωμα, μη μικροκυτταρικός πνεύμονας - Αντινεοπλασματικοί παράγοντες - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
helides gr.cap 20mg/cap
zentiva k.s., prague, czech republic u kabelovny 130,, 102 37, prague 10 - esomeprazole magnesium dihydrate - gr.cap (ΓΑΣΤΡΟΑΝΘΕΚΤΙΚΟ ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 20mg/cap - esomeprazole magnesium dihydrate 21,69mg - esomeprazole